<?xml version="1.0"?>
<Document>

	<Sentence>
		<value>Retinal vein occlusion is a blockage of the small veins that carry blood away from the retina.</value>
		<pattern_crowdsource> [[Retinal vein occlusion|C0035328]] is a blockage of the small [[veins|C0042449]] that carry [[blood|C0005767]] away from the [[retina|C0035298]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>small</surface-form>
				<RDF-ID>C0700321</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>veins</surface-form>
				<RDF-ID>C0042449</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood</surface-form>
				<RDF-ID>C0005767</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retina</surface-form>
				<RDF-ID>C0035298</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0005767 PART_OF C0042449</triple>
			<triple>C0035298 LOCATION_OF C0035328</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Retinal vein occlusion is most often caused by hardening of the arteries (atherosclerosis) and the formation of a blood clot.</value>
		<pattern_crowdsource> Retinal vein occlusion is most often caused by [[hardening|C0702118]] of the [[arteries|C0003842]] (atherosclerosis) and the formation of a blood clot.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>most</surface-form>
				<RDF-ID>C0205393</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>often</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hardening</surface-form>
				<RDF-ID>C0702118</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>arteries</surface-form>
				<RDF-ID>C0003842</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>atherosclerosis</surface-form>
				<RDF-ID>C0004153</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>formation</surface-form>
				<RDF-ID>C1522492</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood clot</surface-form>
				<RDF-ID>C0302148</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0003842 LOCATION_OF C0702118</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Blockage of smaller veins (branch veins or BRVO) in the retina often occurs in places where retinal arteries that have been thickened or hardened by atherosclerosis cross over and place pressure on a retinal vein.</value>
		<pattern_crowdsource> Blockage of smaller veins (branch veins or BRVO) in the retina often occurs in places where retinal arteries that have been thickened or hardened by [[atherosclerosis|C0004153]] cross over and place pressure on a [[retinal vein|C0035327]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>smaller</surface-form>
				<RDF-ID>C0547044</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>veins</surface-form>
				<RDF-ID>C0042449</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>veins</surface-form>
				<RDF-ID>C0042449</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retina</surface-form>
				<RDF-ID>C0035298</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>often</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>places</surface-form>
				<RDF-ID>C0442504</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal arteries</surface-form>
				<RDF-ID>C0035301</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>atherosclerosis</surface-form>
				<RDF-ID>C0004153</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>cross over</surface-form>
				<RDF-ID>C0010366</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>place</surface-form>
				<RDF-ID>C0442504</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pressure</surface-form>
				<RDF-ID>C0234222</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal vein</surface-form>
				<RDF-ID>C0035327</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0035327 LOCATION_OF C0004153</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Risk factors for retinal vein occlusion include:  - Atherosclerosis  - Diabetes  - High blood pressure (hypertension)  - Other eye conditions, such as glaucoma, macular edema, or vitreous hemorrhage    The risk of these disorders increases with age, therefore retinal vein occlusion most often affects older people.</value>
		<pattern_crowdsource> Risk factors for retinal vein occlusion include:  - Atherosclerosis  - Diabetes  - High blood pressure (hypertension)  - Other eye conditions, such as [[glaucoma|C0017601]], [[macular edema|C0271051]], or [[vitreous hemorrhage|C0042909]]    The risk of these [[disorders|C0012634]] increases with age, therefore [[retinal vein occlusion|C0035328]] most often affects older [[people|C0027361]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Risk factors</surface-form>
				<RDF-ID>C0035648</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Atherosclerosis</surface-form>
				<RDF-ID>C0004153</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Diabetes</surface-form>
				<RDF-ID>C0011847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>High blood pressure</surface-form>
				<RDF-ID>C0020538</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hypertension</surface-form>
				<RDF-ID>C0020538</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>conditions</surface-form>
				<RDF-ID>C0348080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>macular edema</surface-form>
				<RDF-ID>C0271051</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vitreous hemorrhage</surface-form>
				<RDF-ID>C0042909</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>risk</surface-form>
				<RDF-ID>C0035647</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disorders</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>age</surface-form>
				<RDF-ID>C0001779</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>often</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>older</surface-form>
				<RDF-ID>C0580836</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0035328 PREDISPOSES C0012634</triple>
			<triple>C0042909 AFFECTS C0027361</triple>
			<triple>C0271051 AFFECTS C0027361</triple>
			<triple>C0017601 AFFECTS C0027361</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Blockage of retinal veins may cause other eye problems, including:  - Glaucoma (high pressure in the eye), caused by new, abnormal blood vessels growing in the front part of the eye  - Macular edema, caused by the leakage of fluid in the retina</value>
		<pattern_crowdsource> Blockage of retinal veins may cause other eye problems, including:  - [[Glaucoma|C0017601]] (high pressure in the eye), caused by new, abnormal blood vessels growing in the front part of the eye  - [[Macular edema|C0271051]], caused by the [[leakage|C0015376]] of fluid in the [[retina|C0035298]]		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>retinal veins</surface-form>
				<RDF-ID>C0035327</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye problems</surface-form>
				<RDF-ID>C0262477</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>high</surface-form>
				<RDF-ID>C0205250</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pressure</surface-form>
				<RDF-ID>C0234222</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>new</surface-form>
				<RDF-ID>C0205314</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>abnormal</surface-form>
				<RDF-ID>C0205161</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessels</surface-form>
				<RDF-ID>C0005847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>front</surface-form>
				<RDF-ID>C0205123</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>part</surface-form>
				<RDF-ID>C0449719</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Macular edema</surface-form>
				<RDF-ID>C0271051</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>leakage</surface-form>
				<RDF-ID>C0015376</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>fluid</surface-form>
				<RDF-ID>C0302908</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retina</surface-form>
				<RDF-ID>C0035298</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0015376 CAUSES C0271051</triple>
			<triple>C0035298 LOCATION_OF C0017601</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Tests to evaluate for vein occlusion include:  - Exam of the retina after dilating the pupil  - Fluorescein angiography  - Intraocular pressure  - Pupil reflex response  - Refraction  - Retinal photography  - Slit lamp examination  - Testing of side vision (visual field examination)  - Visual acuity   Other tests may include:  - Blood tests for diabetes, high cholesterol, and triglyceride levels  - Blood tests to look for a clotting or blood thickening (hyperviscosity) problem (in patients under age 40)    The health care provider will closely monitor any blockage for several months.</value>
		<pattern_crowdsource> Tests to evaluate for vein occlusion include:  - Exam of the retina after [[dilating|C1322279]] the pupil  - Fluorescein angiography  - Intraocular pressure  - Pupil reflex response  - Refraction  - Retinal photography  - Slit lamp examination  - Testing of side vision (visual field examination)  - Visual acuity   Other tests may include:  - Blood tests for [[diabetes|C0011847]], [[high cholesterol|C0848569]], and triglyceride levels  - Blood tests to look for a clotting or blood thickening (hyperviscosity) problem (in patients under age 40)    The health care provider will closely monitor any blockage for several months.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>vein occlusion</surface-form>
				<RDF-ID>C0241669</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Exam</surface-form>
				<RDF-ID>C0031809</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retina</surface-form>
				<RDF-ID>C0035298</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>dilating</surface-form>
				<RDF-ID>C1322279</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pupil</surface-form>
				<RDF-ID>C0034121</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Fluorescein angiography</surface-form>
				<RDF-ID>C0016313</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Intraocular pressure</surface-form>
				<RDF-ID>C0595921</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>response</surface-form>
				<RDF-ID>C0871261</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Retinal photography</surface-form>
				<RDF-ID>C0559963</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Slit lamp examination</surface-form>
				<RDF-ID>C0419360</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Testing</surface-form>
				<RDF-ID>C0039593</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>side</surface-form>
				<RDF-ID>C0441987</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vision</surface-form>
				<RDF-ID>C0042789</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>field</surface-form>
				<RDF-ID>C1521738</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>visual field examination</surface-form>
				<RDF-ID>C0199219</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Visual acuity</surface-form>
				<RDF-ID>C0042812</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>tests</surface-form>
				<RDF-ID>C0392366</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Blood tests</surface-form>
				<RDF-ID>C0018941</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>diabetes</surface-form>
				<RDF-ID>C0011847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>high cholesterol</surface-form>
				<RDF-ID>C0848569</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>triglyceride</surface-form>
				<RDF-ID>C0041004</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>levels</surface-form>
				<RDF-ID>C0441889</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Blood tests</surface-form>
				<RDF-ID>C0018941</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>clotting</surface-form>
				<RDF-ID>C0005778</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood</surface-form>
				<RDF-ID>C0005767</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>thickening</surface-form>
				<RDF-ID>C0205400</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hyperviscosity</surface-form>
				<RDF-ID>C0221104</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>patients</surface-form>
				<RDF-ID>C0030705</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>age</surface-form>
				<RDF-ID>C0001779</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>health care provider</surface-form>
				<RDF-ID>C0018724</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>several</surface-form>
				<RDF-ID>C0443302</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>months</surface-form>
				<RDF-ID>C0439231</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C1322279 TREATS C0011847</triple>
			<triple>C1322279 TREATS C0848569</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>It may take 3 or more months for harmful effects such as glaucoma to develop after the occlusion.</value>
		<pattern_crowdsource> It may take 3 or more months for harmful effects such as [[glaucoma|C0017601]] to develop after the [[occlusion|C0028778]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>more</surface-form>
				<RDF-ID>C0205172</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>months</surface-form>
				<RDF-ID>C0439231</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>effects</surface-form>
				<RDF-ID>C1280500</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>occlusion</surface-form>
				<RDF-ID>C0028778</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0028778 PRECEDES C0017601</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Some people may need to take aspirin or other blood thinners.</value>
		<pattern_crowdsource> Some [[people|C0027361]] may need to take [[aspirin|C0004057]] or other [[blood thinners|C0003280]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>aspirin</surface-form>
				<RDF-ID>C0004057</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood thinners</surface-form>
				<RDF-ID>C0003280</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0004057 ISA C0003280</triple>
			<triple>C0003280 ISA C0004057</triple>
			<triple>C0004057 ADMINISTERED_TO C0027361</triple>
			<triple>C0003280 ADMINISTERED_TO C0027361</triple>
			<triple>C0004057 ADMINISTERED_TO C0027361</triple>
			<triple>C0003280 ADMINISTERED_TO C0027361</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Treatment for the complications of retinal vein occlusion may include:  - Focal laser treatment, if macular edema is present  - Injections of anti-vascular endothelial growth factor (anti-VEGF) drugs into the eye.</value>
		<pattern_crowdsource> Treatment for the [[complications|C0009566]] of retinal vein occlusion may include:  - Focal laser treatment, if macular edema is present  - [[Injections|C1533685]] of anti-[[vascular endothelial growth factor|C1171892]] (anti-VEGF) [[drugs|C0013227]] into the eye.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>complications</surface-form>
				<RDF-ID>C0009566</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Focal</surface-form>
				<RDF-ID>C0205234</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>laser treatment</surface-form>
				<RDF-ID>C0850168</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>macular edema</surface-form>
				<RDF-ID>C0271051</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>present</surface-form>
				<RDF-ID>C0150312</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Injections</surface-form>
				<RDF-ID>C1533685</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vascular endothelial growth factor</surface-form>
				<RDF-ID>C1171892</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C1171892 ISA C0013227</triple>
			<triple>C1533685 TREATS C0009566</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>These drugs may block the growth of new blood vessels that can cause glaucoma.</value>
		<pattern_crowdsource> These [[drugs|C0013227]] may block the [[growth|C0018270]] of new blood vessels that can cause glaucoma.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>growth</surface-form>
				<RDF-ID>C0018270</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>new</surface-form>
				<RDF-ID>C0205314</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessels</surface-form>
				<RDF-ID>C0005847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0013227 AFFECTS C0018270</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Laser treatment to prevent the growth of new, abnormal blood vessels that leads to glaucoma</value>
		<pattern_crowdsource> - [[Laser treatment|C0850168]] to prevent the growth of new, abnormal blood vessels that leads to [[glaucoma|C0017601]]		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Laser treatment</surface-form>
				<RDF-ID>C0850168</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>growth</surface-form>
				<RDF-ID>C0018270</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>new</surface-form>
				<RDF-ID>C0205314</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>abnormal</surface-form>
				<RDF-ID>C0205161</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessels</surface-form>
				<RDF-ID>C0005847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0850168 CAUSES C0017601</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Glaucoma  - Partial or complete vision loss in the affected eye</value>
		<pattern_crowdsource> - Glaucoma  - Partial or complete [[vision loss|C0456909]] in the affected [[eye|C0015392]]		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Glaucoma</surface-form>
				<RDF-ID>C0017601</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Partial</surface-form>
				<RDF-ID>C0728938</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>complete</surface-form>
				<RDF-ID>C0205197</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vision loss</surface-form>
				<RDF-ID>C0456909</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>affected</surface-form>
				<RDF-ID>C0392760</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0015392 LOCATION_OF C0456909</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Retinal vein occlusion is a sign of a general blood vessel (vascular) disease.</value>
		<pattern_crowdsource> [[Retinal vein occlusion|C0035328]] is a [[sign|C0311392]] of a general [[blood vessel|C0005847]] ([[vascular) disease|C0042373]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>sign</surface-form>
				<RDF-ID>C0311392</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>general</surface-form>
				<RDF-ID>C0205246</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessel</surface-form>
				<RDF-ID>C0005847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vascular) disease</surface-form>
				<RDF-ID>C0042373</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0035328 ISA C0042373</triple>
			<triple>C0005847 LOCATION_OF C0311392</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Measures used to prevent other blood vessel diseases may decrease the risk of retinal vein occlusion.</value>
		<pattern_crowdsource> Measures used to prevent other [[blood vessel diseases|C0042373]] may decrease the risk of [[retinal vein occlusion|C0035328]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Measures</surface-form>
				<RDF-ID>C0079809</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessel diseases</surface-form>
				<RDF-ID>C0042373</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>risk</surface-form>
				<RDF-ID>C0035647</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>retinal vein occlusion</surface-form>
				<RDF-ID>C0035328</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0042373 PREDISPOSES C0035328</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>These measures include:  - Eating a low-fat diet  - Getting regular exercise  - Maintaining an ideal weight  - Not smoking    Aspirin or other blood thinners may help prevent blockages in the other eye.</value>
		<pattern_crowdsource> These measures include:  - Eating a low-fat diet  - Getting regular exercise  - Maintaining an ideal weight  - Not smoking    [[Aspirin|C0004057]] or other [[blood thinners|C0003280]] may help prevent blockages in the other eye.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>measures</surface-form>
				<RDF-ID>C0079809</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Eating</surface-form>
				<RDF-ID>C0013470</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>low-fat diet</surface-form>
				<RDF-ID>C0242970</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>regular exercise</surface-form>
				<RDF-ID>C0582191</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>ideal</surface-form>
				<RDF-ID>C1512612</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>weight</surface-form>
				<RDF-ID>C0043100</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Not</surface-form>
				<RDF-ID>C1518422</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Aspirin</surface-form>
				<RDF-ID>C0004057</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood thinners</surface-form>
				<RDF-ID>C0003280</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>eye</surface-form>
				<RDF-ID>C0015392</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0004057 ISA C0003280</triple>
			<triple>C0003280 ISA C0004057</triple>
		</triples>
	</Sentence>

</Document>

